Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2007
11/22/2007WO2007062314A3 Heterocyclic cetp inhibitors
11/22/2007WO2007027225A3 Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/22/2007US20070270492 Nananoic acid derivatives as dipeptidyl peptidase inhibitors
11/22/2007US20070270490 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
11/22/2007US20070270479 New pyrazole derivatives and diabetic medicine containing them
11/22/2007US20070270477 Agent for Prophylaxis or Treatment of Metabolic Syndrome
11/22/2007US20070270464 Prodrugs of curcumin analogs
11/22/2007US20070270463 such as N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-quinol-6-ylmethylsulfonamide; azeotropic distillation, crystallization; central nervous system disorders
11/22/2007US20070270453 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
11/22/2007US20070270450 Compositions for affecting weight loss
11/22/2007US20070270445 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070270411 Novel Diazepine Compounds as Ligands of the Melanocortin 1 and/or 4 Receptors
11/22/2007US20070270408 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines
11/22/2007US20070270388 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
11/22/2007US20070270350 Methods and Compositions for the Prevention and Treatment of Inflammatory Diseases or Conditions
11/22/2007US20070270348 Compositions and Methods for Modulating Insulin-Activated Nitric Oxide Synthase
11/22/2007US20070270340 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer
11/22/2007US20070270337 Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases
11/22/2007US20070270335 Methods for alleviating deleterious effects of 3-deoxyglucosone
11/22/2007US20070270331 Modulators of gluconeogenesis
11/22/2007US20070269536 Purified bilberry extract containing a mixture of glycosides of delphinidin, cyanidin, petunidin, peonidin, and malvidin; no added bisulfite ions; nutraceuticals and pharmaceuticals
11/22/2007US20070269533 Oral Dieting Composition Comprising Conjugated Linoleic Acid and Caffeine
11/22/2007US20070269527 Therapeutic agents for low HDL-cholesterolemia
11/22/2007US20070269516 Controlled release matrix
11/22/2007US20070269513 Liver selective drug therapy
11/22/2007US20070269507 Pharmaceutical Composition
11/22/2007US20070269490 Material for Processed Food for Weight Reduction Diets and Weight Reduction Dietary Processed Food Using Thereof
11/22/2007US20070269421 Diagnostics and Therapeutics for Diseases Associated with Plasma Glutamate Carboxypeptidase (Pgcp)
11/22/2007US20070269393 Topical anesthetic formulation
11/22/2007DE102006021874A1 4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, process for their preparation and their use as medicaments
11/22/2007CA2651968A1 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
11/22/2007CA2651660A1 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
11/22/2007CA2651658A1 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007CA2651657A1 4,5-diphenyl-pyrimidinylamino substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007CA2651466A1 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007CA2650515A1 Benzylamine derivatives as cetp inhibitors
11/22/2007CA2638868A1 Selective vpac2 receptor peptide agonists
11/21/2007EP1857818A1 Diagnostic and therapeutic uses of peptides for pre-forms of type 2 diabetes and conditions associated therewith
11/21/2007EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
11/21/2007EP1857546A1 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
11/21/2007EP1857465A1 Method of producing protein by using hamster igf-1
11/21/2007EP1857457A2 Benzimidazole derivative and its use as AII receptor antagonist
11/21/2007EP1857447A1 Ppar-activating compound
11/21/2007EP1857444A1 Tetrahydroisoquinoline compound and medicinal use thereof
11/21/2007EP1857118A1 Medicinal composition for treating diabetes
11/21/2007EP1857115A2 Using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
11/21/2007EP1857110A2 Hormone replacement therapy
11/21/2007EP1856154A1 Humanized anti-ghrelin antibodies
11/21/2007EP1856090A2 Substituted thiophene derivatives as glucagon receptor antagonists, preparation and therapeutic uses
11/21/2007EP1856072A1 Thiazole derivatives as ppar delta ligands and their manufacturing process
11/21/2007EP1856065A1 1,2,4-triazine derivatives, preparation and use thereof in human therapy
11/21/2007EP1856060A1 Substituted 1,1,1-trifluoro-3-[(benzyl)-(pyrimidin-2-yl)-amino]-prop an-2-ol compounds
11/21/2007EP1856040A2 Novel lipoxygenase inhibitors
11/21/2007EP1855671A1 Oral dosage form comprising rosiglitazone
11/21/2007EP1771444B1 Salt of oxalic acid with 5-[4-[2-(n-methyl-n-(2-pyridyl)-amino)ethoxy]benzyl]thiazolidin-2,4-dione and a method of its preparation and its use
11/21/2007EP1758914B1 Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
11/21/2007EP1623711B1 External patch containing estrogen and/or progestogen
11/21/2007EP1534707B1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007EP1530559B1 Method and device for producing formic acid formates and use of said formates
11/21/2007EP1482920B1 Compositions containing n-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1458383B1 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
11/21/2007EP1385498B1 Fatty acids as neutrophil survival and activation factors.
11/21/2007EP1319064B1 Gsk3 polypeptides
11/21/2007EP1269196B1 Method of screening for inhibitors of osteopontin
11/21/2007EP1263958B1 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
11/21/2007EP0981374B1 Sustained-release delayed gels
11/21/2007EP0871463B2 Regulation of eating behavior
11/21/2007EP0842196B1 Cell adhesion inhibitors
11/21/2007CN101076524A Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
11/21/2007CN101076331A Compositions for treating flushing and lipid-associated disorders comprising niacin receptor partial agonists
11/21/2007CN101076329A Methods for purifying trans-(-)-delta;9-tetrahydrocannabinol and trans-(+)-delta;9-tetrahydrocannabinol
11/21/2007CN101076323A Medicine composition for treating fatmass
11/21/2007CN101073666A Method for producing high-purity kallidin proenzyme raw-material medicine
11/21/2007CN101073628A Method for reducing weight
11/21/2007CN101073627A Method for reducing weight by Chinese medicine
11/21/2007CN101073610A Method for producing haw acid calcium supplementary agent from haw juice extract
11/21/2007CN101073596A Alpha-glycosidase inhibitor, its extraction and use
11/21/2007CN101073584A Method and compositions for altering cell function
11/21/2007CN101073581A Method for preparing iron-complementing agent by complex of parafobrown algin and iron
11/21/2007CN101073574A Medicine for treating diabetes mellitus
11/21/2007CN101073557A Formula of natural beta-carotene sub-micrometer emulsion and its production
11/21/2007CN101073409A Multipurpose medicinal edible food
11/21/2007CN101073408A Nourishing Yuan and removing Gu pills
11/21/2007CN101073386A Malt-sugar alcohol grain for direct tabletting and its production
11/21/2007CN101073364A Production of sweet-potato leaf health-care tea
11/21/2007CN101073357A Fat-lowering cardiotonic tea
11/21/2007CN101073354A Fat-decreasing and weight-reducing tea
11/21/2007CN101073353A Health-care weight-reducing tea
11/21/2007CN101073332A Fat-decreasing biscuit
11/21/2007CN101073329A Calcium-supplementing biscuit
11/21/2007CN100349893C Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007CN100349881C New substituted penta azacyclo salt kind compound and its use in treating protein ageing related disease
11/21/2007CN100349868C Novel indoline compound and medicinal use thereof
11/21/2007CN100349864C Treating syndrome X with substituted tetralins and indanes
11/21/2007CN100349856C Propionic acid derivatives and their use as hPPARs activators
11/21/2007CN100349614C Solid mixture containing alpha-amylase and its prepn process and application in pharmaceutical industry
1 ... 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 ... 1298